RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
HAEMATOLOGICA
Collezione AO Ordine Mauriziano

Items : 61

SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria. in Haematologica / Haematologica. 2024 Jan 1;109(1):283-286. doi: 10.3324/haematol.2023.283863.

2024
AO Ordine Mauriziano
AOU Novara

De Latour RP; De la Camara R; Orvain C; Risitano AM; Gavriilaki E; Lanza F; Drexler B; Beier F; Cignetti A; Loschi M; Szmigielska-Kaplon A; Patriarca A; Drozd-Sokolowska J; Xicoy B; Giammarco S; Zaidi U; Desnica L; Fattizzo B; Ingram W; Tjon JM; Verheggen I; Kulagin A; Eikema DJ; Griffin M;

Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study. in Haematologica / Haematologica. 2024 Aug 15. doi: 10.3324/haematol.2024.285638.

2024
AOU Novara
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Candoni A; Foa R; Ferrara F; Pizzolo G; Bassan R; Starza ID; Fanin R; Luppi M; Marsili G; Vignetti M; Piciocchi A; Mancini V; De Bellis E; Trastulli F; Ciccone M; De Gobbi M; Cignetti A; Mazzone C; Aprile L; Mauro E; Fanin M; Chiusolo P; Minetto P; Defina M; Delia M; Pasciolla C; Grimaldi F; Cambo B; Santoro L; et alii...

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.

2023
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
ASL Cuneo 1
AOU Novara

Fazi P; Vignetti M; Piciocchi A; Cuneo A; Foà R; Guarini A; Nanni M; Neri A; De Propris MS; De Novi LA; Visentin A; Vitale C; Albano F; Molinari MC; Pietrasanta D; Mattiello V; Liberati AM; Giordano A; Gottardi D; Patrizi VB; Galieni P; Musuraca G; Deodato M; Arcari A; Tani M; Levato L; Marchetti M; Massaia M; Rigolin GM; et alii...

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study. in Haematologica / Haematologica. 2022 Oct 1;107(10):2356-2364. doi: 10.3324/haematol.2021.280175.

2022
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Baccarani M; Cavo M; Saglio G; Pane F; Foà R; Simula MP; Albano F; Soverini S; Porretto F; Sorà F; Cavazzini F; Trabacchi E; Cedrone M; Bocchia M; Tiribelli M; Martino B; Rege-Cambrin G; Salvucci M; Stagno F; D'Adda M; Intermesoli T; Levato L; Breccia M; Castagnetti F; Gugliotta G; Rosti G;

Second-Line Bosutinib in Elderly CML Patients: Final Results of Best Study in Haematologica

2020
AO Ordine Mauriziano

Baccarani M; Rosti G; Spinosa G; Ferrero D; Rapezzi D; Ladetto M; Scortechini AR; Cedrone M; Spadano R; Trabacchi E; Lunghi M; Lunghi F; Stagno F; Pregno P; Iurlo A; Albano F; Luciano L; Sorà F; Saglio G; Pane F; Nocilli L; Cavo M; Bergamaschi M; Lucchesi A; Elena C; Binotto G; Crugnola M; Rege-Cambrin G; Bonifacio M; et alii...

Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study. in Haematologica / Haematologica. 2019 Jan;104(1):e4-e8. doi: 10.3324/haematol.2017.183590. Epub 2018 Aug 3.

2019
ASL Torino 5
ASL Torino 4
AO Ordine Mauriziano
AO Cuneo
AOU Città della Salute di Torino

Levis A; Saglio G; Musto P; Bonferroni M; Finelli C; Tassara R; Ferrero D; Cametti G; Poloni A; Balleari E; Sanna A; Allione B; Danise P; Salvi F; Ceccarelli M; Castiglione A; Masiera E; Gioia D; Messa E; Santini V;

Clinical significance of MR2 at one year and beyond: A GIMEMA CML WP analysis on 559 CML patients treated frontline with imatinib mesylate in Haematologica

2019
AO Ordine Mauriziano

Castagnetti F; Gugliotta G; Breccia M; Stagno F; Iurlo A; Albano F; Abruzzese E; Martino B; Levato L; Intermesoli T; Pregno P; D'Adda M; Calistri E; Rupoli S; Cavazzini F; Ferrero D; Caocci G; Bocchia M; Tiribelli M; Montefusco E; Sorà F; Bonifacio M; Elena C; Soverini S; Foà R; Cavo M; Pane F; Saglio G; Baccarani M; et alii...

Efficacy and safety of front-line treatment with ibrutinib and rituximab in unfit patients with chronic lymphocytic leukemia (CLL). First report of the GIMEMA LLC1114 study in Haematologica

2019
ASL Asti
AO Ordine Mauriziano

Mauro FR; Molica S; Paoloni F; Reda G; Trentin L; Marchetti M; Pietrasanta D; Coscia M; Marasca R; Sportoletti P; Gaidano G; Orsucci L; Stelitano C; Di Renzo N; Liberati M; Gottardi D; Re F; Ilariucci F; Zinzani PL; Mannina D; Gozzetti A; Molinari AL; Gentile M; Chiarenza A; Laurenti L; Varettoni M; Ibatici A; Murru R; Tani M; et alii...

Present results and future perspectives in optimizing chronic myeloid leukemia therapy. in Haematologica / Haematologica. 2018 Jun;103(6):928-930. doi: 10.3324/haematol.2017.182022.

2018
AO Ordine Mauriziano

Carella AM; Saglio G; Mahon XF; Mauro MJ;

NGS-based prospective assessment of low burden mutation dynamics in chronic myeloid leukemia patients with failure and warning responses: The 'Next-in-CML' study in Haematologica

2018
AO Ordine Mauriziano

Soverini S; Bavaro L; Martelli M; De Benedittis C; Stella S; Iurlo A; Orofino N; Barate C; Galimberti S; Sica S; Sora F; Russo Rossi A; Albano F; Ciceri F; Lunghi F; Castagnetti F; Gugliotta G; Tenti E; Rosti G; Papayannidis C; Stagno F; Vigneri P; Serra A; Saglio G; Carnuccio F; Pane F; Errichiello S; Annunziata M; Breccia M; et alii...

Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. in Haematologica / Haematologica. 2017 Sep;102(9):e352-e355. doi: 10.3324/haematol.2016.156901. Epub 2017 Jun 8.

2017
AO Ordine Mauriziano
AOU Città della Salute di Torino
AO Cuneo

Piciocchi A; Boncompagni R; Orlando S; Cuneo A; Galieni P; Marasca R; Vannata B; Pozzato G; Efremov DG; Molica S; Coscia M; Massaia M; D'Arena G; Del Poeta G; Mannina D; Mauro FR; Ciolli S; Autore F; Innocenti I; Laurenti L; Vincelli D; Liberati AM; Russo F; Foá R;

The EUTOS long-term survival scoring system is predictive for Response and outcome in chronic myeloid leukemia patients treated frontline with nilotinib in Haematologica

2017
AO Ordine Mauriziano

Castagnetti F; Gugliotta G; Breccia M; Stagno F; D'adda M; Levato L; Angelucci E; Martino B; Tiribelli M; Fava C; Binotto G; Avanzini P; Bocchia M; Bergamaschi M; Russo-Rossi A; Cavazzini F; Abruzzese E; Soverini S; Foà R; Cavo M; Martinelli G; Saglio G; Pane F; Baccarani M; Rosti G;

Front-line treatment of BCR-ABL+ chronic myeloid leukemia with dasatinib: A prospective multicentric observational study in Haematologica

2017
AO Ordine Mauriziano

Castagnetti F; Gugliotta G; Breccia M; Sorà F; Iurlo A; Gozzini A; Scortechini AR; Luciano L; Stagno F; Malato A; Abruzzese E; Crugnola M; Pregno P; Specchia G; Musto P; Cascavilla N; Tiribelli M; Bonifacio M; Galieni P; Palmieri F; Soverini S; Bochicchio MT; Sica S; Foà R; Cavo M; Martinelli G; Saglio G; Pane F; Baccarani M; et alii...

Erythropoietin stimulating agents greatly improve anemia in patients with myelofibrosis treated with ruxolitinib in Haematologica

2017
AO Ordine Mauriziano

Crisà E; Cilloni D; Elli EM; Martinelli V; Pugliese N; Grimaldi F; Beggiato E; Frairia C; Cerrano M; Lanzarone G; Marchetti M; Mezzabotta M; Boccadoro M; Ferrero D;

Establishing a national network of laboratories performing BCR-ABL kinase domain mutation screening by NEXT generation amplicon deep sequencing: Results of the 'NEXT-IN-CML' study in Haematologica

2017
AO Ordine Mauriziano

Soverini S; De Benedittis C; Bavaro L; Martelli M; Stella S; Iurlo A; Orofino N; Baratè C; Galimberti S; Sica S; Sorà F; Rossi AR; Albano F; Ciceri F; Lunghi F; Castagnetti F; Gugliotta G; Tenti E; Rosti G; Papayannidis C; Stagno F; Vigneri P; Serra A; Saglio G; Carnuccio F; Pane F; Errichiello S; Annunziata M; Breccia M; et alii...

Rate and reasons of 5-azacytidine discontinuation and subsequent therapeutic options in 418 MDS patients from the Italian MDS registry of Fondazione Italiana Sindromi Mielodisplastiche (FISM) in Haematologica

2017
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Clavio M; Gioia D; Ceccarelli M; Monagheddu C; Balleari E; Miglino M; Di Tucci AA; Allione B; Poloni A; Finelli C; Aguzzi C; Selleri C; Danise P; Cilloni D; Gaidano V; Cavaliere M; Calzamiglia T; Freilone R; Cametti G; Conconi AR; Mezzabotta M; Goretti R; Musto P; Gaidano G; Pane F; Angelucci E; Levis A; Santini V;

Erythropoiesis stimulating agents can improve anemia in patients with myelofibrosis treated with ruxolitinib in Haematologica

2017
ASL Asti
AO Ordine Mauriziano

Crisà E; Daniela C; Elli EM; Beggiato E; Frairia C; Cerrano M; Lanzarone G; Marchetti M; Mezzabotta M; Boccadoro M; Ferrero D;

Early chemotherapy intensification with escalated BEACOPP in advanced-stage Hodgkin lymphoma with a positive interim PET-CT after 2 ABVD cycles: Long-term results of the GITIL/FIL HD 0607 trial in Haematologica

2017
AO Ordine Mauriziano

Gallamini A; Rossi A; Patti K; Picardi M; Romano A; Cantonetti M; La Nasa G; Trentin L; Bolis S; Rapezzi D; Viviani S; Gianni AM; Zoli V; Gottardi D; Tarella C; Gavarotti P; Corradini P; Cimminiello M; Schiavotto C; Parvis G; Zanotti R; Gini G; Ferreri AJ; Viero P; Miglino M; Billio A; Avigdor A; Prosperini G; Bergesio F; et alii...

Rate and causes of 5-azacytidine discontinuation and subsequent therapeutic options in 418 MDS patients from the Italian MDS registry of fondazione Italiana sindromi mielodisplastiche (FISM) in Haematologica

2017
ASL Biella
ASL Torino 5
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Mezzabotta M; Conconi AR; Cametti G; Freilone R; Calzamiglia T; Cavaliere M; Gaidano V; Cilloni D; Danise P; Selleri C; Aguzzi C; Finelli C; Poloni A; Allione B; Di Tucci AA; Miglino M; Balleari E; Monagheddu C; Ceccarelli M; Gioia D; Clavio M; Santini V; Gaidano G; Pane F; Angelucci E; Levis A; Goretti R; Musto P;

Impact of BCR-ABL1 transcript type in chronic myeloid leukemia treated frontline with nilotinib in Haematologica

2017
AO Ordine Mauriziano

Castagnetti F; Gugliotta G; Breccia M; Stagno F; D'Adda M; Levato L; Angelucci E; Martino B; Tiribelli M; Fava C; Binotto G; Capodanno I; Bocchia M; Bergamaschi M; Russo-Rossi A; Cavazzini F; Abruzzese E; Soverini S; Foà R; Cavo M; Martinelli G; Saglio G; Pane F; Baccarani M; Rosti G;

Sequential high-dose cytarabine plus idarubicin improves remission rate and survival duration in adult acute myelogenous leukemia (AML): Randomized trial of the Northern Italy leukemia group (NILG) in Haematologica

2016
AOU Alessandria
AO Ordine Mauriziano
AO Cuneo

Bassan R; Intermesoli T; Masciulli A; Boschini C; Gianfaldoni G; Marmont F; Cavattoni I; Mattei D; Terruzzi E; De Paoli L; Rossi G; Borlenghi E; Ciceri F; Bernardi M; Scattolin AM; Todisco E; Campiotti L; Corradini P; Cortelezzi A; Tajana M; Ferrero D; Cignetti A; Marfisi RM; Delaini F; Zanghì P; Oldani E; Spinelli O; Audisio E; Cortelazzo S; et alii...

Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A. in Haematologica / Haematologica. 2015 Jul;100(7):881-92. doi: 10.3324/haematol.2014.123117. Epub 2015 Apr 24.

2015
AO Ordine Mauriziano

Zanolini D; Merlin S; Feola M; Ranaldo G; Amoruso A; Gaidano G; Zaffaroni M; Ferrero A; Brunelleschi S; Valente G; Gupta S; Prat M; Follenzi A;

Novel CALR somatic mutations in essential thrombocytemia in Haematologica

2015
AO Ordine Mauriziano

Riera L; Osella-Abate S; Benevolo G; Beggiato E; Ferrero S; Pich A; Francia Di Celle P;

Pegylated interferon-a prolongs survival in patients with polycythemia vera: The turin experience in Haematologica

2015
AO Ordine Mauriziano

Crisà E; Garvey KB; Benevolo G; Aguzzi C; Nicolino B; Borchiellini A; Beggiato E; Manzini P; Francia P; Riera L; Vitolo U; Boccadoro M; Ferrero D;

Efficacy and safety of chlorambucil plus rituximab as front-line therapy in elderly and/or unfit patients with chronic lymphocytic leukemia. A gimema retrospective study in Haematologica

2015
AO Ordine Mauriziano

Laurenti L; Autore F; Innocenti I; Vannata B; Ciolli S; Mauro FR; Mannina D; Del Poeta G; D'Arena G; Massaia M; Coscia M; Molica S; Pozzato G; Marasca R; Galieni P; Cuneo A; Orlando S; Piciocchi A; Boncompagni R; Vincelli D; Liberati AM; Russo F; Foà R;

Pegylated interferon treatment improves survival in polycythemia vera patients: A single center experience in Haematologica

2015
AO Ordine Mauriziano

Crisà E; Garvey K; Benevolo G; Aguzzi C; Barbara N; Borchiellini A; Beggiato E; Manzini P; Francia Di Celle P; Riera L; Vitolo U; Boccadoro M; Ferrero D;

High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem cell transplant in patients with systemic b-cell lymphoma and secondary central nervous system involvement: Final results of a multicenter Phase II trial in Haematologica

2015
AO Ordine Mauriziano

Bruno-Ventre M; Doa G; D'Arco AM; Di Nicola M; Tarella C; Zambello R; Mian M; Patti C; Cabras MG; Citterio G; Foppoli M; Ferreri AJM; Fanni A; Mulè A; Calimeri T; Ciceri F; Caligaris-Cappio F; Sassone M; Scarfò L;

High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem cell transplant in systemic B-cell lymphomas with CNS involvement: A multicenter phase II trial in Haematologica

2014
AO Ordine Mauriziano

Caligaris-Cappio F; Ciceri F; Mulè A; Pinotti G; Bruno Ventre M; Foppoli M; Fanni A; Di Nicola M; D'Arco AM; Doa G; Zambello R; Tarella C; Cabras MG; Patti C; Milan M; Ferreri AJ; Donadoni G;

The lymphocytes to monocytes ratio identifies a patient subgroup among high risk DLBCL that may benefit from upfront intensive treatment with autograft in Haematologica

2013
AO Ordine Mauriziano

Barbui AM; Masciulli A; Scarano M; Delaini F; Rossi A; Ladetto M; Corradini P; Di Nicola M; Patty C; Mulè A; Zanni M; Zoli V; Billio A; Gallamini A; Di Raimondo F; Ferreri AJM; Benedetti F; Leoni P; Semenzato G; Frezzato M; Flenghi L; Marchioli R; Barbui T; Gianni AM; Tarella C; Cortelazzo S; Rambaldi A;

Frequency and clinical outcome of primary refractory disease in nonhodgkin's lymphoma: A retrospective survey on 3,492 newly diagnosed patients undergoing first-line chemotherapy in Haematologica

2013
AO Ordine Mauriziano

Tarella C; Gueli A; Delaini F; Rossi A; Barbui A; Gritti G; Caracciolo D; Hu H; Gottardi D; Passera R; Rambaldi A;

Telomere loss is an early and persistent abnormality in leukocytes from patients treated with conventional chemotherapy but not from those exposed to rituximab alone in Haematologica

2013
AO Ordine Mauriziano

Gueli A; Risso A; Spatola T; Hu H; Gottardi D; De Crescenzo A; Buttiglieri S; Tarella C;

Telomere analysis shows that hematopoiesis in recipients of umbilical cord blood is biologically younger compared to the age-matched healthy population in Haematologica

2013
AO Ordine Mauriziano

Tarella C; Risso A; Spatola T; Ruella M; Milone G; Pioltelli P; Iori AP; Di Bartolomeo P; Rambaldi A; Bacigalupo A; Arcese W;

Addition of rituximab to involved-field radiotherapy prolongs progression free survival in stage I-II follicular lymphomas: A multicentric, retrospective survey in Haematologica

2012
AO Ordine Mauriziano

Ruella M; Filippi A; Di Russo A; Matteucci P; Caracciolo D; Passera R; Magni M; Di Nicola M; Montefusco V; Parvis G; Gini G; Ladetto M; Ricardi U; Tarella C; Gianni AM; Devizzi L;

Cell-therapy with HLA-mismatched mobilized peripheral blood stem cells after standard chemotherapy in elderly patients with acute myeloid leukemia: Preliminary data on feasibility and safety in Haematologica

2012
AO Ordine Mauriziano
AOU Città della Salute di Torino

Cignetti A; Ruella M; Hu H; Elia A; Tassi V; Redoglia V; Gottardi D; Tarella C;

Structure and evolution of a newly developed Italian archive of PNH clones in Haematologica

2012
AO Ordine Mauriziano

Cannizzo E; Sartori M; Triolo AM; Lo Pardo C; Buccisano F; Tedone E; Messana F; Oliva BM; Ottaviano V; Carulli G; Poletti G; De Propris MS; Stacchini A; Vanelli L; Perbellini O; Arpinati M; Bartocci C; Gervasi F; Armentano Conte C; Lanza F; Geuna M; Del Vecchio L;

Early and persistent telomere shortening in leukocytes from patients treated with conventional chemotherapy but not from those exposed to rituximab alone in Haematologica

2012
AO Ordine Mauriziano

Gueli A; Risso A; Ruella M; Spatola T; Hu H; Gottardi D; De Crescenzo A; Buttiglieri S; Tarella C;

Role of whole body magnetic resonance including diffusion weighted imaging in the initial staging of lymphoma in Haematologica

2012
AO Ordine Mauriziano

Tarella C; Cirillo S; Hu H; Gueli A; Ruella M; Petracchini M; Gottardi D; Lario C; De Crescenzo A; Balbo-Mussetto A; Saviolo C;

Pre-emptive rituximab-based treatment of molecular relapses in follicular and mantle cell lymphoma in Haematologica

2012
AO Ordine Mauriziano

Ferrero S; Monitillo L; Mantoan B; Barbero D; Genuardi E; Bruna R; Bernocco E; Caracciolo D; Ruella M; Drandi D; Zanni M; Gueli A; Renna F; Ghione P; Lobetti Bodoni C; Barbiero S; Musto P; Boccadoro M; Tarella C; Ladetto M;

Short course of granulocyte-colony stimulating factor to accelerate wound repair in patients undergoing surgery for sacro-coccygeal pilonidal cyst: Proof of concept in Haematologica

2012
AO Ordine Mauriziano

Ruella M; Fronticelli CM; Scuderi S; Monni M; Passera R; Omede' P; Tarella C;

Retargeting of citokine-induced killer (CIK) cells with molecularly engrafted T-cell receptors (TCR): A preclinical study in Haematologica

2011
AO Ordine Mauriziano

Elia A; Circosta P; Geuna M; Sangiolo D; Tarella C; Cignetti A;

Efficacy of lenalidomide as single agent to control minimal residual disease in chronic lymphocytic leukemia in first complete remission in Haematologica

2011
AO Ordine Mauriziano

Ruella M; De Crescenzo A; Gottardi D; Prato G; Geuna M; Gueli A; Tarella C;

Telomere shortening is an early aging sign following exposure to cytotoxic drugs: Assessment both in vitro on cultured mesenchymal stem cells and in vivo on cells from patients undergoing chemotherapy in Haematologica

2011
AO Ordine Mauriziano

Risso A; Buttiglieri S; Gueli A; Spatola T; Avvedimento EV; De Crescenzo A; Gottardi D; Mezzabotta M; Ruella M; Tarella C;

Pre-operative bone marrow-derived cell mobilization by G-CSF (granulocyte-colony stimulating factor) enhances osseointegration of bone substitute in patients undergoing surgery with high tibial valgus osteotomy in Haematologica

2011
AO Ordine Mauriziano

Tarella C; Rossi P; Borrè A; Ruella M; Risso A; Marenco S; Giacalone F; Tron A; Rossi R; Castoldi F; Marmotti A;

Accelerated telomere shortening is an early and permanent signature in cultured human mesenchymal stem cells exposed to chemotherapy in Haematologica

2011
AO Ordine Mauriziano

Tarella C; Avvedimento V; Silengo L; Spatola T; Risso A; Ruella M; Buttiglieri S;

VMPT (bortezomib, melphalan, prednisone and thalidomide) followed by maintenance with bortezomib-thalidomide (VT) is active and well tolerated in newly diagnosed patients with multiple myeloma (MM) with moderate renal impairment (RI) ineligible for autologous stem cell transplantation: Results from a cohort analysis of a phase III randomized controlled trial in Haematologica

2011
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Morabito F; Gentile M; Mazzone C; Rossi D; Ria R; Offidani M; Patriarca F; Nozzoli C; Petrucci M; Benevolo G; Vincelli I; Guglielmelli T; Grasso M; Marasca R; Baldini L; Musto P; Liberati A; Cascavilla N; Cangialosi C; Majolino I; Musolino C; Zambello R; Di Raimondo F; Cavo M; Boccadoro M; Palumbo A;

Telomere length is reduced in ph-negative chronic myeloproliferative neoplasms according to JAK2 V617F mutation allele burden but it is maintained in secondary erythrocytosis in Haematologica

2010
AO Ordine Mauriziano

Ruella M; Salmoiraghi S; Risso A; Carobbio A; Sivera P; Ricca I; Barbui T; Tarella C; Rambaldi A;

The vitamin nicotinamide enhances the activation of the p53/miR-34a/SIRT1 tumor suppressor network in chronic lymphocytic leukemia in Haematologica

2010
AO Ordine Mauriziano

Audrito V; Vaisitti T; Serra S; Rossi D; Gottardi D; D'Arena G; Gaidano G; Malavasi F; Deaglio S;

Exposure of cultured mesenchymal stem cells to chemotherapy: A simple and reliable procedure to investigate the molecular mechanisms of stem cell senescence in Haematologica

2010
AO Ordine Mauriziano

Avvedimento E; Tarella C; Tracchi S; Montanini M; Risso A; Ruella M; Spatola T; Buttiglieri S;

Feasibility, safety and therapeutic potential of systemic pre-operative bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy in Haematologica

2010
AO Ordine Mauriziano

Tarella C; Rossi P; Borrè A; Ruella M; Risso A; Realmuto C; Marenco S; Giacalone F; Tron A; Rossi R; Castoldi F; Marmotti A;

Generation of a T-cell clone directed against AML blasts that recognizes a tumor specific antigen expressed also by solid tumors in Haematologica

2010
AO Ordine Mauriziano

Elia A; Circosta P; Russo V; Mele L; Allione B; Tarella C; Cignetti A;

An allo-restricted peptide-specific CD8+ T-cell clone directed against the universal tumor antigen survivin in Haematologica

2010
AO Ordine Mauriziano

Circosta P; Elia A; Orso F; Tarella C; Cignetti A;

Telomere loss in ph- negative chronic myeloproliferative neoplasms: The role of JAK2 V617F mutation allele burden and the influence of the history of the illness in Haematologica

2010
AO Ordine Mauriziano

Ruella M; Salmoiraghi S; Risso A; Carobbio A; Sivera P; Mezzabotta M; Ricca I; Barbui T; Tarella C; Rambaldi A;

G-CSF-induced bone marrow-derived stem cells mobilization before sacrococcygeal pilonidal cyst surgery in Haematologica

2010
AO Ordine Mauriziano

Ruella M; Scuderi S; Monni M; Omedè P; Fronticelli Baldelli C; Tarella C;

The long-term outcome of high-risk follicular lymphoma patients receiving intensive therapy with autograft as primary treatment: Results from three consecutive prospective trials performed in Italy over the past 18 years in Haematologica

2009
AO Ordine Mauriziano

Corradini P; Gianni AM; Pileri A; Passera R; Ruella M; Ladetto M; Tarella C;

Factors influencing the occurrence of secondary myelodysplastic syndrome/acute leukemia following high-dose therapy and autograft: A GITIL (Gruppo Italiano Terapie innovative nei linfomi) survey in 1,347 lymphoma patients in Haematologica

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Passera R; Magni M; Rossi A; Gueli A; Benedetti F; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Corradini P; Zoli V; Leone M; Bosa M; Barbui A; Di Nicola M; Boccadoro M; Sorio M; Gianni AM; Rambaldi A;

Bendamustin in association with rituximab (BR)in the treatment of patiens with relapsed/refractory lymphoid neoplasm. A GISL retrospective study in Haematologica

2009
AO Ordine Mauriziano

Iannitto E; Augello A; Carpaneto A; Chisesi T; Di Renzo N; Ferrara F; Fizzotti M; Liardo E; Madrigali S; Mancuso S; Montanaro M; Montanini A; Musso M; Musto P; Pennese E; Rota-Scalabrini D; Scalone R; Stelitano C; Abbadessa V; Federico M;

Limited stage low-grade lymphoma patients receiving Rituximab combined with localized radiotherapy: The long-term follow-up shows prolonged survival with low incidence of disease recurrence in Haematologica

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Caracciolo D; Ruella M; Bazzan M; Parvis G; Ladetto M; Boccadoro M; Mistretta A; Patti C; Todisco L; Franco P; Ricardi U; Filippi AR;

Modified DHAP schedule containing oxaliplatin (OX-DHA) is effective and widely applicable in Chronic Lymphocytic Leukemia and Waldestrom disease in Haematologica

2009
AO Ordine Mauriziano

Ricca I; Ruella M; Gueli A; Gottardi D; Caracciolo D; Bergui L; Gavarotti P; Boccadoro M; Tarella C;

Accelerated telomere shortening in Ph - Negative Chronic Myeloproliferative Neoplasms: Comparison with the healthy population and correlations with treatment received in Haematologica

2009
AO Ordine Mauriziano

Ruella M; Salmoiraghi S; Risso A; Sivera P; Barbui T; Rambaldi A; Tarella C;

Histology and rituximab addition are the main factors influencing the long-term outcome in high-risk lymphoma following high-dose therapy and autograft: A 20-yr. Follow-up in 1,347 patients by gitil (gruppo italiano terapie innovative NEI Linfomi) in Haematologica

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Di Nicola M; Rossi A; Caracciolo D; Passera R; Benedetti F; Patti C; Parvis G; Ciceri F; Castellino C; Cortelazzo S; Corradini P; Majolino I; Mule' A; Bosa M; Barbui A; Magni M; Boccadoro M; Sorio M; Rambaldi A; Gianni AM;

Analysis of T-cell clones in systemic lupus erythematosus. in Haematologica / Haematologica. 2000 Feb;85(2):118-23.

2000
AO Ordine Mauriziano

Converso M; Bertero MT; Vallario A; Caligaris-Cappio F;